Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Instruments (Legacy through FY2025Q4) by Quarter
Instruments (Legacy through FY2025Q4) — U.S. Net Sales ($M) ($M)
Stryker Instruments (Legacy through FY2025Q4): $606M in Q3 2025, up 11.4% from a year earlier.
Latest, Q3 2025
606
Period ended Sep 30, 2025
Change on a year earlier
+11.4%
544 in Q3 2024
History
15 quarters
Since Q1 2021
Sources
12
Documents cited below
Where the Q3 2025 figure comes from
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Stryker Instruments (Legacy through FY2025Q4) ($M), quarterly Q1 2021–Q3 2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/leg-inst-us
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.